Skip to content
Trial Eligibility
Menu

Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase

NCT05820919

This study is recruiting at 3 US sites in 3 states, according to its ClinicalTrials.gov record last updated .

Summary

This study seeks to improve clinical outcomes for an important, growing, and vulnerable population-nursing home residents with Alzheimer's disease or related dementias-by testing an evidence-based intervention to improve these residents' sleep. It will also examine the implementation and sustainment of this intervention.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Alzheimer Disease
  • Dementia
  • Sleep Disorder
  • Sleep Disturbance

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
50 years and older
Sex
All
Healthy volunteers
Not accepted
Sponsor
University of Alabama, Tuscaloosa
Last updated on ClinicalTrials.gov
March 12, 2024

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Colorado · 1

  • Vivage/Beecan Corporation · Lakewood, CO

Tennessee · 1

  • National HealthCare Corporation · Murfreesboro, TN

Texas · 1

  • Caraday Healthcare, LLC · San Marcos, TX

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.